CLINICAL_TRIALS
trial_result
· 2019-01-04
Clinical Trial Update: Study on the Safety and Efficacy of Dalbavancin Versus Active Comparator in Adult Participants With Osteomyelitis [Phase 2]
Summary
Phase 2 trial comparing dalbavancin to an active comparator for osteomyelitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Durata Therapeutics Inc., an affiliate of Allergan plc | Conditions: Osteomyelitis | Phase 2 | Status: COMPLETED | Results posted: 2019-01-04